Analysis of survival in 400 surgically resected non-small cell lung carcinomas: Towards a redefinition of the T factor

Journal of Thoracic Oncology

Volumn 3, Issue 9, 2008, Pages 989-993

  Lyons, Gustavo ^a   Quadrelli, Silvia ^a,b   Silva, Carlos ^a   Vera, Karina ^a   Iotti, Alejandro ^a   Venditti, Julio ^a   Chertcoff, Julio ^a   Chimondeguy, Domingo ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

Mediastinal metastases; Non small cell lung cancer; TNM classification

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG HILUS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; CANCER STAGING; FOLLOW UP; LUNG TUMOR; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58149140384     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181838b19     Document Type: Article

References (36)

1. International Union Against Cancer. Lung tumours. In: Sobin L, Witte-kind C, (Eds.), TNM Classification of Malignant Tumors, 5th ed. New York: Wiley-Liss; 1997.
2. International Union Against Cancer. Lung tumours. In: Sobin L, Witte-kind C, (Eds.), TNM Classification of Malignant Tumors, 6th ed. New York: Wiley-Liss; 2002.
3. Mountain CF. Revision in the international system for staging lung cancer. Chest 1997;111:1710-1717.
4. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
5. Watanabe Y, Shimizu J, Oda M, et al. Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer. Jpn J Clin Oncol 1991;21:160-168.
6. Patz EF Jr., Rossi S, Harpole DH Jr., Herndon JE, Goodman PC. Correlation of tumor size and survival in patients with stage IA non-small-cell lung cancer. Chest 2000;117:1568-1571.
7. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: Japanese experience. Ann Thorac Surg 2001;71: 1759-1764.
8. Carbone E, Asamura H, Takei H, et al. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. J Thorac Cardiovasc Surg 2001;122:907-912.
9. Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 2005;79:1142-1146.
10. Kramer H, Groen HJ. Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 2003;238:180-188.
11. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histologicaltyping of Lung and Pleural Tumours, World Health Organization. 3rd ed. Berlin: Springer, 1999.
12. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723.
13. Rami-Porta R, Wittekind C, Goldstraw. P Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005;49:25-33.
14. Cox D. Regression models and life-table (with discussion). J R Statist Soc B 1972;34:187-2205.
15. Pelletier MP, Edwards MD, Michel RP, Halwani F, Morin JE. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 2001;44:180-188.
16. Strauss GM. Prognostic markers in resectable non-small cell lung cancer. Hematol Oncol Clin North Am 1997;11:409-434.
17. Heyneman LE, Herndon JE, Goodman PC, Patz EF. Stage distribution in patients with a small (-3cm) primary nonsmall cell lung carcinoma. Implication for lung carcinoma screening. Cancer 2001;92:3051-3055.
18. Birim O, Kappetein AP, Takkenberg JJM, Van Klaveren RJ, Bogers AJ. Survival after pathological stage IA non-small cell lung cancer: tumor size matters. Ann Thorac Surg 2005;79:1137-1141.
19. Riquet M, Manac'h D, Le Pimpec Barthes F, Dujon A, Debrosse D, Debesse B. Prognostic value of T and N in nonsmall cell lung cancer three centimeters or less in diameter. Eur J Cardiothorac Surg 1997;11: 440-444.
20. Yanagi S, Sugiura H, Morikawa T, et al. Tumor size does not have prognostic significance in stage IA NSCLC. Anticancer Res 2000;20: 1155-1158.
21. Rena O, Oliaro A, Caballo A, et al. Stage I non-small cell lung carcinoma: really an early stage? Eur J Cardiothorac Surg 2002;21:514 -519.
22. Lyons G, Quadrelli S, Chimondegy D, Iotti A, Silva C. Impacto del tamaño del tumor en la sobrevida del carcinoma de pulmon IA. Medicina. 2008;68:23-30.
23. National Comprehensive Cancer Network. Clinical practice guidelines in oncology, v. 2;2005. Available at: http://www.nccn.org. Accessed December 8, 2007.
24. Available at: http://cancer.gov/cancerinfo/pdg/cancerdatabase. Accessed November 30, 2007.
25. National Institute for Clinical Excellence. Lung cancer: the diagnosis and treatment of lung cancer. Available at: http://www.nice.org.uk/ CG024NICEguideline. Accessed November 30, 2007.
26. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004;22:3860-3867.
27. Sedrakyan A, van der Meulen J, O'Byrne K, Prendiville J, Hill J, Treasure T. Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004; 128:414-419.
28. Hamada C, Tanaka F, Ohta M, et al. Meta-analysis of postoperative adjuvant chemotherapy with Tegafur-Uracil in non-small-cell lung cancer. J Clin Oncol 2005;23:4999-5006.
29. Berghmans T, Paesmans M, Meerta AP, et al. Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer 2005;49:13-23.
30. Douillard J, Rosell R, Delena M, Legroumellec A, Torres A, Carpagnano F. ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up. Proceedings of the 2005 ASCO Annual Meeting. J Clin Oncol 2004;23:Abstract 7013.
31. Kato H, Ichinose Y, Ohta M, et al. Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N EngI J Med 2004;350:1713-1721.
32. van Rens MTM, de la Riviere AB, Elbers HR, van Den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-379.
33. Jassem J, Skokowski J, Dziadziuszko R, et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardiovasc Surg 2000; 119:1141-1146.
34. Rami-Porta R, Ball D, Crowley J, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593-602.
35. Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. Early peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002;74: 1635-1639.
36. Goya T, Asamura H, Yoshimura H, et al. The Japanese Joint Committee of Lung Cancer Registry.Lung Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Cancer 2005;50:227-234.